Breyer Capital | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Breyer Capital/Activity

Breyer Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· MAY 2026Show all

Investment

Participated in Catena Labs' $30M Series A for AI-native banking infrastructure, alongside Acrew Capital and a16z crypto.

Catena Labs

Catena Labs Breyer Capital

fortune.comMAY 20, 2026

MAY 20, 2026

Investment

Participated in Catena Labs' $18M seed round (led by a16z) for a company building new Internet identity, communications, AI, and commerce infrastructure.

Catena Labs

Catena Labs Breyer Capital

crowdfundinsider.com

Added recently

Investment

Backed SandboxAQ, an Alphabet spin-out combining AI and quantum computing for life sciences, data security, and clean energy applications.

Sandbox AQ

Sandbox AQ Breyer Capital

sandboxaq.com

Added recently

Talk

Jim Breyer participated as a speaker at the Milken Institute Global Conference 2025.

Jim Breyer at Milken Institute Global Conference 2025

Breyer Capital

milkeninstitute.org

Added recently

Investment

Led ParcelBio's $13M seed financing to advance next-generation mRNA medicines.

ParcelBio

ParcelBio Breyer Capital

businesswire.comMAY 7, 2026

MAY 7, 2026

Investment

Participated in Soley Therapeutics' $200M Series C to advance its oncology pipeline and cell stress sensing platform.

Soley Therapeutics

Soley Therapeutics Breyer Capital

businesswire.comJAN 7, 2026

JAN 7, 2026

Essay

Published 2026 healthcare and life sciences predictions centered on computation, precision, and prevention.

Breyer Capital 2026 Healthcare and Life Sciences Predictions

Breyer Capital

morgancheatham.substack.comJAN 2026

JAN 2026

Team Change

Appointed Dr. Bret Bostwick as Venture Advisor to strengthen the healthcare and life sciences practice.

Dr. Bret Bostwick joined as Venture Advisor

Breyer Capital

businesswire.comDEC 19, 2025

DEC 19, 2025

Team Change

Appointed Dr. Bret Bostwick (FAAP, FACMG), physician-scientist at Alnylam Pharmaceuticals, as Venture Advisor to expand healthcare and life sciences investment capabilities.

Dr. Bret Bostwick joins as Venture Advisor

Breyer Capital

businesswire.comDEC 2025

DEC 2025

3 investments· MAY 2025 – SEP 2025Show all

Investment

Participated in Harbor Health's $225M+ growth round; Harbor Health provides primary and specialty care with integrated health insurance.

Harbor Health

Harbor Health Breyer Capital

parsers.vcSEP 2025

SEP 2025

Investment

Led Jarsy's $5M pre-seed round for a Web3 platform that tokenizes access to private equity investments.

Jarsy

JarsyBreyer Capital

theblock.coJUN 2025

fintech.global

JUN 2025

Investment

Participated in Wander's $50M Series B for its luxury vacation rental platform.

Wander

Wander Breyer Capital

prnewswire.comMAY 28, 2025

MAY 28, 2025

Team Change

Appointed Morgan Cheatham, MD as Partner and Head of Healthcare and Life Sciences, joining from Bessemer Venture Partners VP role where he sourced Abridge and Hinge Health.

Morgan Cheatham joins as Partner and Head of Healthcare and Life Sciences

Breyer Capital

businesswire.comAPR 2025

APR 2025

Press

Jim Breyer appeared on CNBC's Money Movers to discuss the Stargate Project investment in AI infrastructure and Breyer Capital's AI thesis.

Jim Breyer discusses Stargate Project and AI Infrastructure on CNBC

Breyer Capital

cnbc.comJAN 2025

JAN 2025

Page 1 of 2